Our poor understanding of the functional properties of polycystin-1, polycystin-2, and the polycystin-1/polycystin-2 complex impedes the development of therapeutic strategies; ADPKD is currently treated by dialysis and kidney transplant (LaRiviere et al., 2015). Here, PKD2 is linked to autosomal dominant polycystic kidney disease.